Improved long‐term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancer

Author:

Jia Zi‐Yao123,Zhu Yi‐Di234,Wu Xiang‐Song234,Yang Jing‐Xiao123,Wu Wen‐Guang1,Wang Xu‐An1,He Min1,Wang Hui1,Yang Lin‐Hua1,Zhang Jie1,Li Xue‐Chuan12356,Zou Lu12356,Li Huai‐Feng234,Zhang Fei234,Bao Run‐Fa234,Cui Xu‐Ya12356,Song Xiao‐Ling234,Chen Wei1,Gong Wei234ORCID,Li Mao‐Lan12356,Liu Ying‐Bin12356ORCID

Affiliation:

1. Department of Biliary‐Pancreatic Surgery, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai China

2. Shanghai Key Laboratory of Biliary Tract Disease Research Shanghai China

3. Shanghai Research Center of Biliary Tract Disease Shanghai China

4. Department of General Surgery Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China

5. State Key Laboratory of Oncogenes and Related Genes Shanghai China

6. Shanghai Cancer Institute Shanghai China

Abstract

AbstractBackgroundThree‐dimensional visualization preoperative evaluation (3D‐VPE) and enhanced recovery after surgery (ERAS) have been suggested to improve outcomes of cancer surgery in patients, yet little is known regarding their clinical benefit in patients with gallbladder cancer (GBC). We hypothesized that the combination of 3D‐VPE and ERAS would improve the outcome of patients undergoing surgery for GBC.ObjectiveThis study aimed to determine if 3D‐VPE and ERAS can improve the outcomes and overall survival in patients with GBC, establishing a novel patient management strategy for GBC.MethodsA total of 227 patients with GBC were recruited and divided into two groups: those who received traditional treatment between January 2000 and December 2010 (n = 86; the control group) and those who underwent 3D‐VPE and ERAS between January 2011 and December 2017 (n = 141). Univariate and multivariate analyses were employed to assess the relationship among disease stages, lymph node invasion, and cell differentiation between the two groups. Cox regression analysis was used to investigate patient survival in these groups.ResultsPatients who underwent 3D‐VPE and ERAS showed a significantly higher R0 resection rate (67.4% vs. 20.9%, p < 0.001) and dissected lymph node number (26.6 ± 12.6 vs. 16.3 ± 7.6 p < 0.001) compared to the control group. The median survival was 27.4 months, and the 1‐ and 3‐year survival rates were 84.4% and 29.8%, respectively, in patients who received combined management; in the control cohort, the median survival was 12.7 months, and the 1‐ and 3‐year survival rates were 53.5% and 15.1%, respectively. In addition, some postoperative complications and risk factors were diminished relative to the traditionally treated patients.ConclusionThe implementation of 3D‐VPE and ERAS can significantly improve the prognosis and outcomes of patients with GBC and should be considered for wide use in clinical practice.

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference32 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Analysis of treatment modalities and prognosis of patients with gallbladder cancer in China from 2010 to 2017;Ren T;Zhonghua Wai Ke Za Zhi,2020

3. Routine examination of gallbladder specimens after cholecystectomy: a single‐Centre analysis of the incidence, clinical and histopathological aspects of incidental gallbladder carcinoma;Mauro DD;Discov Oncol,2021

4. Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico

5. Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3